Security National Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,153
Closed -$1.6M 393
2021
Q2
$1.6M Sell
12,153
-255
-2% -$33.4K 0.36% 77
2021
Q1
$1.59M Buy
12,408
+180
+1% +$22.2K 0.37% 75
2020
Q4
$1.46M Buy
12,228
+410
+3% +$50K 0.36% 73
2020
Q3
$1.35M Hold
11,818
0.38% 72
2020
Q2
$1.35M Buy
11,818
+1,016
+9% +$108K 0.4% 71
2020
Q1
$868K Sell
10,802
-16
-0.1% -$1.66K 0.32% 78
2019
Q4
$1.16M Sell
10,818
-95
-0.9% -$9.91K 0.34% 78
2019
Q3
$1.17M Hold
10,913
0.37% 77
2019
Q2
$1.11M Sell
10,913
-100
-0.9% -$9.61K 0.35% 76
2019
Q1
$990K Sell
11,013
-120
-1% -$10.4K 0.32% 78
2018
Q4
$927K Sell
11,133
-250
-2% -$23.4K 0.34% 77
2018
Q3
$1.23M Sell
11,383
-25
-0.2% -$2.74K 0.39% 73
2018
Q2
$1.25M Hold
11,408
0.42% 69
2018
Q1
$1.15M Sell
11,408
-31
-0.3% -$3.17K 0.38% 71
2017
Q4
$1.13M Sell
11,439
-222
-2% -$21K 0.36% 75
2017
Q3
$1.09M Sell
11,661
-334
-3% -$35.5K 0.36% 77
2017
Q2
$1.33M Sell
11,995
-50
-0.4% -$5.29K 0.45% 68
2017
Q1
$1.18M Sell
12,045
-125
-1% -$11.9K 0.4% 71
2016
Q4
$1.12M Sell
12,170
-75
-0.6% -$6.46K 0.4% 68
2016
Q3
$1.04M Sell
12,245
-100
-0.8% -$8.4K 0.38% 70
2016
Q2
$1M Sell
12,345
-116
-0.9% -$8.83K 0.37% 72
2016
Q1
$890K Sell
12,461
-914
-7% -$61.3K 0.33% 77
2015
Q4
$951K Sell
13,375
-100
-0.7% -$6.72K 0.37% 72
2015
Q3
$828K Sell
13,475
-116
-0.9% -$8.11K 0.32% 76
2015
Q2
$986K Sell
13,591
-100
-0.7% -$7.38K 0.35% 73
2015
Q1
$1.05M Sell
13,691
-400
-3% -$28.6K 0.37% 70
2014
Q4
$945K Sell
14,091
-655
-4% -$41.3K 0.34% 72
2014
Q3
$895K Sell
14,746
-37
-0.3% -$2.28K 0.36% 69
2014
Q2
$868K Sell
14,783
-1,525
-9% -$89.3K 0.34% 73
2014
Q1
$945K Sell
16,308
-1,150
-7% -$61.6K 0.38% 71
2013
Q4
$934K Sell
17,458
-450
-3% -$26.7K 0.39% 68
2013
Q3
$1.11M Buy
17,908
+1,058
+6% +$63.3K 0.5% 56
2013
Q2
$1.02M Buy
+16,850
New +$1M 0.49% 55

Other funds holding DGX

Security National Trust's DGX Position: Q3 2021 in Review

Security National Trust sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 12,153 shares — an estimated $1.6M sold.

Security National Trust first reported a position in DGX in Q2 2013 and held it in 33 quarters. The position peaked at $1.6M in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Security National Trust reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Security National Trust sold 12,153 Quest Diagnostics shares in Q3 2021, an estimated $1.6M.
  • Security National Trust first reported a position in Quest Diagnostics in Q2 2013 and held it in 33 quarters.
  • Security National Trust's Quest Diagnostics position peaked at $1.6M in Q2 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.